文献速递中毒与环境急症心脑血管急症

费城非法阿片类药物供应中暴露于美托咪定患者的临床特征——病例系列

Clinical characteristics of patients exposed to medetomidine in the illicit opioid drug supply in Philadelphia - a case series.
PubMed 文献 · Clin Toxicol (Phila) · 2025-05-21
一句话结论非法阿片类药物中掺杂美托咪定的患者主要表现为窦性心动过缓,持续时间中位3.4小时,无需阿托品、起搏或升压药,均存活。

该回顾性病例系列纳入11例因非法阿片类药物过量就诊且确诊暴露于美托咪定的急诊患者。全血美托咪定浓度为1.2 μg/L至16 μg/L。患者窦性心动过缓中位持续3.4小时,低血压不常见。6例住院,1例入住ICU,全部存活。所有病例芬太尼和赛拉嗪检测阳性,其他掺杂剂常见。心动过缓在早期药物研究确定的5个半衰期内消退,无需阿托品、电起搏或升压药治疗低血压,且心动过缓的持续时间和程度与美托咪定浓度相关性不佳。

要点

  • 确诊美托咪定暴露的非法阿片类过量患者,窦性心动过缓中位持续3.4小时,需延长监测。
  • 全血美托咪定浓度范围1.2 μg/L至16 μg/L,心动过缓持续时间和程度与浓度相关性不佳。
  • 低血压不常见,无患者因低血压需要阿托品、电起搏或升压药。
  • 11例中6例住院、1例入住ICU,全部存活;所有病例芬太尼和赛拉嗪检测阳性。

适用人群与场景

  • 因非法阿片类药物过量就诊于急诊科且确诊暴露于美托咪定的患者。

红旗征与不能漏的情况

  • 窦性心动过缓:11例患者中位持续3.4小时,需延长监测。

研究设计与关键结果

  • 回顾性病例系列,纳入11例因非法阿片类药物过量就诊且确诊美托咪定暴露的急诊患者。
  • 全血美托咪定浓度为1.2 μg/L至16 μg/L。
  • 窦性心动过缓中位持续3.4小时,低血压不常见。
  • 6例住院,1例入住ICU,全部存活。
  • 所有病例芬太尼和赛拉嗪检测阳性,其他掺杂剂常见。
  • 心动过缓在早期药物研究确定的5个半衰期内消退,无患者需要阿托品、电起搏或升压药治疗低血压。
  • 心动过缓的持续时间和程度与美托咪定浓度相关性不佳。

证据类型、等级与局限

  • 证据类型:回顾性病例系列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 确诊美托咪定暴露的非法阿片类过量患者需延长监测,因窦性心动过缓中位持续3.4小时。
  • 心动过缓的持续时间和程度与美托咪定浓度相关性不佳,血药浓度不能预测临床病程。
  • 低血压不常见,无患者需要阿托品、电起搏或升压药治疗低血压。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Medetomidine is an emerging adulterant in the illicit opioid drug supply with minimal data regarding clinical effects or blood concentrations after uncontrolled exposures in humans.

METHODS: A retrospective case series was performed of patients presenting to the emergency department after illicit opioid overdose with confirmed exposure to medetomidine. Patient outcomes and clinical data were summarized with descriptive statistics.

RESULTS: Eleven patients were included in the series. Whole blood medetomidine concentrations ranged from 1.2 μg/L to 16 µg/L. Patients had sinus bradycardia for a median of 3.4 h, and hypotension was not common. Six cases were admitted to the hospital, one to the intensive care unit, and all survived. All cases tested positive for fentanyl and xylazine, and other adulterants were common.

DISCUSSION: Sinus bradycardia was the most salient finding of patients with confirmed medetomidine exposure from the illicit opioid supply. Bradycardia resolved within the expected five half-lives determined by early drug studies, and no patient required atropine, electrical pacing, or vasopressors for hypotension. The duration and degree of bradycardia did not correlate well with medetomidine concentrations.

CONCLUSION: In this retrospective case series, patients who tested positive for medetomidine had sinus bradycardia and required prolonged monitoring.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Murphy L, Krotulski A, Hart B, et al. Clinical characteristics of patients exposed to medetomidine in the illicit opioid drug supply in Philadelphia - a case series. Clin Toxicol (Phila). 2025. PMID: 40396666. doi:10.1080/15563650.2025.2500601

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。